Aditxt, Inc. (ADTX)
Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform designed to empower individuals by providing insights into their immune profiles for better management and informed awareness of immune system attacks or dysfunctions. Aditxt also pioneers Apoptotic DNA Immunotherapy, a nucleic acid-based solution that emulates the body's inherent mechanisms for developing self-tolerance to its own tissues. Additionally, Aditxt is actively researching and developing ADi products with diverse therapeutic applications, such as for organ transplant procedures (including skin grafting), various autoimmune conditions, and allergic reactions. The company holds licensing agreements with esteemed institutions like Loma Linda University and Leland Stanford Junior University. Established in 2017, this Richmond, Virginia-headquartered company was initially known as ADiTx Therapeutics, Inc. before rebranding to Aditxt, Inc. in July 2021.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Aditxt, Inc.
OTC:ADTXHealthcare · Biotechnology
$0.0003
Mkt Cap$299K
Float997.98M
O/S997.98M
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$3K
Net Income-$41.71M
Total Assets$16.52M
Free Cash Flow-$25.7B
Debt & Equity
Debt 35%
Equity 65%
Preferred 0%
Total Debt$3.01M
Total Equity$5.61M
Preferred Stock$27
Shares Outstanding
Short Interest
Split History7 splits · 7 reverse
2-year cumulative
1:6,102,000Over cap
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:27Reverse splitMay 18, 202627 shares → 1
- 1:8Reverse splitMar 9, 20268 shares → 1
- 1:113Reverse splitNov 3, 2025113 shares → 1
- 1:250Reverse splitMar 17, 2025250 shares → 1
- 1:40Reverse splitOct 2, 202440 shares → 1
- 1:40Reverse splitAug 18, 202340 shares → 1
- 1:50Reverse splitSep 14, 202250 shares → 1
Balance Sheet Details
Assets$16.52M
Liabilities$12.56M
Accounts Receivable$0
Accounts Payable$7.34M
Inventory$6K
PP&E (Net)$2.08M
Goodwill$0
Intangible Assets$3K
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $3K | $134K | $645K | $934K | $105K | $0 | $0 | $0 | $0 |
| YoY Growth | -97.6% | -79.2% | -30.9% | 789.0% | - | - | - | - | - |
| Cost of Revenue | $3K | $627K | $757K | $767K | $78K | $18K | $0 | $0 | $0 |
| Gross Profit | $268 | -$493K | -$112K | $167K | $27K | -$18K | $0 | $0 | $0 |
| Gross Margin | 8.4% | -368.0% | -17.3% | 17.9% | 25.8% | - | - | - | - |
| Research and Development | $3.19M | $10.89M | $7.07M | $7.27M | $5.04M | $938K | $175K | $525K | $0 |
| Selling, General, and Administrative | $16.38M | $16.48M | $18.88M | $17.84M | $22.42M | $7.92M | $5.7M | $5.08M | $213K |
| Other | $0 | $0 | $0 | $544K | $14.5M | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $19.57M | $27.37M | $25.95M | $25.65M | $41.96M | $8.85M | $5.87M | $5.61M | $213K |
| Operating Income (EBIT) | -$19.57M | -$27.86M | -$26.06M | -$25.48M | -$41.94M | -$8.87M | -$5.87M | -$5.61M | -$213K |
| Operating Margin | -612542.2% | -20796.4% | -4039.6% | -2728.9% | -39925.2% | - | - | - | - |
| Interest Expense | $2.39M | $7.36M | $6.39M | $2.29M | $1.94M | $310K | $2K | $80K | $0 |
| Interest Income | $200K | $1K | $10K | $57K | $3K | $563 | $2K | $0 | $0 |
| Other Income (Expense) | -$23.22M | -$7.16M | -$6.33M | -$2.17M | -$4.44M | -$277K | $43K | -$80K | $0 |
| Income Before Tax (EBT) | -$42.79M | -$35.02M | -$32.39M | -$27.65M | -$46.37M | -$9.15M | -$5.83M | -$5.69M | -$852K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$852K |
| Net Income | -$41.71M | -$34.45M | -$32.38M | -$27.65M | -$46.37M | -$9.15M | -$5.83M | -$5.69M | -$213K |
| Net Income Margin | -1305608.8% | -25708.8% | -5018.9% | -2961.3% | -44148.6% | - | - | - | - |
| Supplementary Data | |||||||||
| EPS | -1153.83 | -3062.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Diluted EPS | -1153.83 | -3062.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Average OS | 37,355 | 11,248 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -$40.13M | -$27.04M | -$25.46M | -$24.83M | -$43.96M | -$8.82M | $45K | $471 | $639K |
| EBITDA Margin | -1255918.2% | -20180.6% | -3945.9% | -2659.1% | -41850.3% | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $3.2M | $833K | $97K | $2.77M | $7.87M | $10.5M | $4K | $116K | $25K |
| Short-Term Investments | $0 | $832.2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $3.2M | $833.03M | $97K | $2.77M | $7.87M | $10.5M | $4K | $116K | $25K |
| Accounts Receivable | $0 | $1.15M | $5.85M | $528K | $590K | $0 | $0 | $0 | $0 |
| Inventory | $6K | $11K | $746K | $950K | $495K | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | -$885.71M | $0 | $0 | $0 | $385K | $0 | $0 | $0 |
| Total Current Assets | $3.82M | $2M | $6.91M | $4.74M | $9.42M | $11.03M | $4K | $116K | $25K |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $2.08M | $2.77M | $4.1M | $5.48M | $6.36M | $1.67M | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $3K | $6K | $9K | $107K | $214K | $321K | $0 | $0 | $0 |
| Long-Term Investments | $6.65M | $27.28M | $22.28M | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $398K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $3.96M | -$310K | $11.28M | $405K | $669K | $72K | $119K | $0 | $0 |
| Total Long-Term Assets | $12.7M | $30.14M | $37.67M | $5.99M | $7.25M | $2.06M | $119K | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $16.52M | $32.14M | $44.58M | $10.74M | $16.66M | $13.1M | $124K | $116K | $25K |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $7.34M | $10.19M | $8.55M | $1.96M | $1.58M | $242K | $1.85M | $1.06M | $9K |
| Short-Term Debt | $1.86M | $5.8M | $16.18M | $410K | $700K | $588K | $166K | $164K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | -$1.96M | -$1.58M | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $1.86M | $4.48M | $159K | $2.15M | $1.76M | $7K | $0 | $0 | $51K |
| Total Current Liabilities | $12.22M | $23.41M | $25.89M | $3.64M | $3.61M | $1.23M | $2.98M | $1.65M | $60K |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $110K | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $15K | $1.6M | $0 | $0 | $0 | $0 | $0 | $25K |
| Total Long-Term Liabilities | $343K | $451K | $2.64M | $1.89M | $2.88M | $858K | $0 | $1.22M | $25K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.22M | $0 |
| Total Liabilities | $12.56M | $23.86M | $28.53M | $5.53M | $6.48M | $2.09M | $2.98M | $1.65M | $85K |
| Stockholders' Equity | |||||||||
| Preferred Stock | $27 | $8.37M | $25 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $412 | $130 | $1K | $4K | $45K | $13K | $4K | $8K | $7K |
| Retained Earnings | -$209.81M | -$168.09M | -$127.74M | -$95.04M | -$67.35M | -$20.88M | -$11.73M | -$5.9M | -$213K |
| Comprehensive Income & Other | $1.25M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $215.42M | $176.96M | $143.8M | $100.24M | $77.49M | $31.88M | $8.87M | $4.36M | $146K |
| Total Equity | $5.61M | $8.87M | $16.06M | $5.21M | $10.18M | $11.01M | -$2.85M | -$1.54M | -$60K |
| Minority Interest | -$1.66M | -$583K | -$10K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $18.17M | $32.73M | $44.59M | $10.74M | $16.66M | $13.1M | $124K | $116K | $25K |
| Supplementary Data | |||||||||
| Total Debt | $3.01M | $6.92M | $18.22M | $3.38M | $4.72M | $1.84M | $166K | $164K | $0 |
| Net Debt | -$192K | $6.09M | $18.12M | $613K | -$3.15M | -$8.66M | $162K | $48K | -$25K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$42.79B | -$34.45M | -$32.38M | -$27.65M | -$46.37M | -$9.15M | -$5.83M | -$5.69M | -$852K |
| Depreciation & Amortization | $273K | $617K | $543K | $536K | $476K | $18K | $5.87M | $5.61M | $852K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $17M | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $473.31M | $6.75M | $1.4M | $3.13M | $4.64M | $3.19M | $4.23M | $3.52M | $612K |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | $43K | $365K | $120K | -$37K | -$90K | $0 | $0 | $0 | $0 |
| Inventory | $5K | $734K | $205K | -$455K | -$495K | $0 | $0 | $0 | $0 |
| Accounts Payable | -$5.63M | $5.1M | $6.65M | $413K | $1.33M | -$1.48M | $602K | $1.05M | $0 |
| Other Working Capital | -$588K | $900K | $2.13M | -$414K | -$619K | -$95K | $530K | $381K | $205K |
| Total Working Capital Change | -$6.17M | $7.09M | $9.1M | -$493K | $130K | -$1.58M | $1.13M | $1.43M | $205K |
| Other Non-Cash Items | $16.63B | $3.23M | $2.76M | $2.08M | $1.85M | $300K | -$5.87M | -$5.26M | -$818K |
| Net Cash from Operating | -$25.69B | -$16.76M | -$18.58M | -$22.39M | -$22.28M | -$7.22M | -$464K | -$386K | $0 |
| Investing Activities | |||||||||
| Capital Expenditures | -$13.74M | $0 | -$14K | -$367K | -$1.02M | -$171K | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$2.42M | -$5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | -$2.42B | $0 | $0 | $125K | -$15.29M | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$2.44B | -$5M | -$14K | -$242K | -$16.31M | -$171K | $0 | $0 | $0 |
| Financing Activities | |||||||||
| Debt Repaid | - | - | $262K | $412K | -$3.56M | -$317K | - | - | - |
| Common Stock Issuance | $44.13M | $22.41M | $11.06M | $17.23M | $29.87M | $18.5M | $470K | $631K | $0 |
| Common Stock Repurchases | -$9.21M | -$2.85M | -$1K | -$20K | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $30.46B | $5.58M | $628K | $709K | $2.53M | -$45K | -$119K | -$274K | $100K |
| Net Cash from Financing | $30.49B | $22.5M | $16.55M | $17.53M | $35.95M | $17.89M | $353K | $477K | $100K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $2.37B | $736K | -$2.67M | -$5.1M | -$2.63M | $10.5M | -$112K | $91K | $100K |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$25.69B | -$16.76M | -$18.58M | -$22.39M | -$22.28M | -$7.22M | -$464K | -$386K | $0 |
| Capital Expenditure | -$13.74M | $1 | -$14K | -$367K | -$1.02M | -$171K | $0 | $0 | $0 |
| Free Cash Flow | -$25.7B | -$16.76M | -$18.59M | -$22.76M | -$23.29M | -$7.39M | -$464K | -$386K | $0 |
| Cash at Beginning | $833.03M | $97K | $2.77M | $7.87M | $10.5M | $4K | $116K | $25K | $0 |
| Cash at End | $3.2B | $833K | $97K | $2.77M | $7.87M | $10.5M | $4K | $116K | $100K |